Prana raises US$3.7 million
Wednesday, 08 December, 2004
A number of US institutional investors have purchased and exercised 9.5 million options in Prana Biotechnology (NASDAQ: PRAN, ASX: PBT) at $0.50 per share, raising US$3.7 million for the company.
The options - originally owned by directors and insiders of Prana - were exercised prior to their scheduled expiry date of December 1, 2004.
The exercise of options increases the total issued shares in Prana to 126,890,821.
Common arthritis drug also lowers blood pressure
Scientists have known for a while that methotrexate helps with inflammation, but it may also help...
AI enables precise gene editing
A newly developed tool utilises AI to predict how cells repair their DNA after it is cut by gene...
Shingles vaccine may reduce risk of heart attack and stroke
Vaccination with either the recombinant herpes zoster vaccine or the live-attenuated zoster...
